More
    Guided Solutions - Connecting Talent With Innovation/div>

    ShiraTronics concludes migraine therapy pilot study in Australia

    Clinical-stage medical device company ShiraTronics has completed its pilot study in Australia for its implantable migraine therapy system. The device is designed to alleviate the...

    Carthera kicks off pivotal trial with blood-brain-barrier opening device

    Carthera has enrolled the first patient in a pivotal trial evaluating its low-intensity pulsed ultrasound (LIPUS)-based technology which helps drugs reach the brain in...

    SoniVie completes enrolment in trial of ultrasound renal denervation for hypertension

    SoniVie announced today that it treated the last patient in a pilot study of its Tivus technology for renal artery denervation to treat hypertension. Tel...

    App designed to track macular degeneration triumphs in clinical trial

    French digital health firm, Tilak Healthcare, has announced positive results from a clinical trial of a mobile app aimed at allowing patients with chronic...

    Iridex enrols first patient in clinical study evaluating treatment of glaucoma with MicroPulse TLT

    Iridex Corp and Imperial College Healthcare NHS Trust in London announced the first patient enrolment in a collaborative medical research study and registry evaluating...

    Axena begins study to explore barriers to UI treatment for women

    Axena Health has commenced a study to explore the barriers women encounter when seeking first-line treatment for urinary incontinence (UI) and faecal incontinence (FI). Related:...

    Cognito starts biomarker substudy in Alzheimer’s device trial

    Cognito Therapeutics has enrolled the first patient in a biomarker substudy within its HOPE pivotal trial evaluating sensory stimulation device in Alzheimer’s disease patients. Related:...

    Nectero starts clinical trial for endovascular aneurysm stabilisation system

    Arizona-based Nectero Medical has initiated a Phase II/III trial evaluating the safety and efficacy of its endovascular aneurysm stabilisation treatment (Nectero EAST). Nectero EAST is...

    OrganOx and eGenesis advance in porcine liver replacement trial

    OrganOx and eGenesis have announced the successful completion of an extracorporeal perfusion of a brain-dead research donor using a genetically engineered porcine liver. The...

    Latest articles